110 related articles for article (PubMed ID: 18089699)
1. Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance.
Langeveld M; Ghauharali KJ; Sauerwein HP; Ackermans MT; Groener JE; Hollak CE; Aerts JM; Serlie MJ
J Clin Endocrinol Metab; 2008 Mar; 93(3):845-51. PubMed ID: 18089699
[TBL] [Abstract][Full Text] [Related]
2. Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease.
Ghauharali-van der Vlugt K; Langeveld M; Poppema A; Kuiper S; Hollak CE; Aerts JM; Groener JE
Clin Chim Acta; 2008 Mar; 389(1-2):109-13. PubMed ID: 18164265
[TBL] [Abstract][Full Text] [Related]
3. In vivo regulation of non-insulin-mediated and insulin-mediated glucose uptake by epinephrine.
Baron AD; Wallace P; Olefsky JM
J Clin Endocrinol Metab; 1987 May; 64(5):889-95. PubMed ID: 2881942
[TBL] [Abstract][Full Text] [Related]
4. Rates and tissue sites of noninsulin- and insulin-mediated glucose uptake in diabetic rats.
Lang CH
Proc Soc Exp Biol Med; 1992 Jan; 199(1):81-7. PubMed ID: 1728041
[TBL] [Abstract][Full Text] [Related]
5. Impairment of noninsulin-mediated glucose disposal in the elderly.
Meneilly GS; Elahi D; Minaker KL; Sclater AL; Rowe JW
J Clin Endocrinol Metab; 1989 Mar; 68(3):566-71. PubMed ID: 2563735
[TBL] [Abstract][Full Text] [Related]
6. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans.
Baron AD; Brechtel G; Wallace P; Edelman SV
Am J Physiol; 1988 Dec; 255(6 Pt 1):E769-74. PubMed ID: 3059816
[TBL] [Abstract][Full Text] [Related]
7. Metabolic consequences of adipose triglyceride lipase deficiency in humans: an in vivo study in patients with neutral lipid storage disease with myopathy.
Natali A; Gastaldelli A; Camastra S; Baldi S; Quagliarini F; Minicocci I; Bruno C; Pennisi E; Arca M
J Clin Endocrinol Metab; 2013 Sep; 98(9):E1540-8. PubMed ID: 23824421
[TBL] [Abstract][Full Text] [Related]
8. No difference in glycosphingolipid metabolism and mitochondrial function in glucocorticoid-induced insulin resistance in healthy men.
Brands M; van Raalte DH; João Ferraz M; Sauerwein HP; Verhoeven AJ; Aerts JM; Diamant M; Serlie MJ
J Clin Endocrinol Metab; 2013 Mar; 98(3):1219-25. PubMed ID: 23386653
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with pioglitazone does not protect obese patients with diabetes mellitus type II from free fatty acid-induced insulin resistance.
Serlie MJ; Allick G; Groener JE; Ackermans MT; Heijligenberg R; Voermans BC; Aerts JM; Meijer AJ; Sauerwein HP
J Clin Endocrinol Metab; 2007 Jan; 92(1):166-71. PubMed ID: 17062758
[TBL] [Abstract][Full Text] [Related]
10. Fasting decreases rates of noninsulin-mediated glucose uptake in man.
Baron AD; Brechtel G; Wallace P; Edelman SV
J Clin Endocrinol Metab; 1988 Sep; 67(3):532-40. PubMed ID: 3045143
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the properties of the cell membrane due to glycosphingolipid accumulation in a model of Gaucher disease.
Batta G; Soltész L; Kovács T; Bozó T; Mészár Z; Kellermayer M; Szöllősi J; Nagy P
Sci Rep; 2018 Jan; 8(1):157. PubMed ID: 29317695
[TBL] [Abstract][Full Text] [Related]
12. Hepatic insulin resistance in antipsychotic naive schizophrenic patients: stable isotope studies of glucose metabolism.
van Nimwegen LJ; Storosum JG; Blumer RM; Allick G; Venema HW; de Haan L; Becker H; van Amelsvoort T; Ackermans MT; Fliers E; Serlie MJ; Sauerwein HP
J Clin Endocrinol Metab; 2008 Feb; 93(2):572-7. PubMed ID: 18029467
[TBL] [Abstract][Full Text] [Related]
13. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?
Burén J; Lindmark S; Renström F; Eriksson JW
Metabolism; 2003 Feb; 52(2):239-45. PubMed ID: 12601640
[TBL] [Abstract][Full Text] [Related]
14. Glycosphingolipid analysis in a naturally occurring ovine model of acute neuronopathic Gaucher disease.
Karageorgos L; Hein L; Rozaklis T; Adams M; Duplock S; Snel M; Hemsley K; Kuchel T; Smith N; Hopwood JJ
Neurobiol Dis; 2016 Jul; 91():143-54. PubMed ID: 26976737
[TBL] [Abstract][Full Text] [Related]
15. Sphingolipids: the nexus between Gaucher disease and insulin resistance.
Fuller M
Lipids Health Dis; 2010 Oct; 9():113. PubMed ID: 20937139
[TBL] [Abstract][Full Text] [Related]
16. TNFalpha-induced insulin resistance in adipocytes as a membrane microdomain disorder: involvement of ganglioside GM3.
Kabayama K; Sato T; Kitamura F; Uemura S; Kang BW; Igarashi Y; Inokuchi J
Glycobiology; 2005 Jan; 15(1):21-9. PubMed ID: 15306563
[TBL] [Abstract][Full Text] [Related]
17. The fate of glucosylceramide (glucocerebroside) in genetically impaired (lysosomal beta-glucosidase deficient) Gaucher disease diploid human fibroblasts.
Saito M; Rosenberg A
J Biol Chem; 1985 Feb; 260(4):2295-300. PubMed ID: 3919000
[TBL] [Abstract][Full Text] [Related]
18. Gram-negative infection increases noninsulin-mediated glucose disposal.
Lang CH; Dobrescu C
Endocrinology; 1991 Feb; 128(2):645-53. PubMed ID: 1989854
[TBL] [Abstract][Full Text] [Related]
19. Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease.
Nascimbeni F; Dalla Salda A; Carubbi F
Blood Cells Mol Dis; 2018 Feb; 68():74-80. PubMed ID: 27839982
[TBL] [Abstract][Full Text] [Related]
20. Regulation of glucose homeostasis in humans with denervated livers.
Perseghin G; Regalia E; Battezzati A; Vergani S; Pulvirenti A; Terruzzi I; Baratti D; Bozzetti F; Mazzaferro V; Luzi L
J Clin Invest; 1997 Aug; 100(4):931-41. PubMed ID: 9259593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
